Fulltext

Monographs on drugs which are frequently analyzed in therapeutic drug monitoring

Rentsch, Working group "Drug Monitoring” of the SSCC: Katharina ; Eap, Chin Bin ; Fathi, Marc ; Grignaschi, Nathalie ; Magnin, Jean-Luc ; Thormann, Wolfgang ; Todesco, Liliane ; Werner, Dominique

In: LaboratoriumsMedizin, 2008, vol. 32, no. 5, p. 372-381

Zum persönliche Liste hinzufügen
    Titel
    • Monographs on drugs which are frequently analyzed in therapeutic drug monitoring
    Autor
    • Rentsch, Working group "Drug Monitoring” of the SSCC: Katharina. University Hospital Zurich, Zurich, Switzerland
    • Eap, Chin Bin. University Hospital Lausanne, Lausanne, Switzerland
    • Fathi, Marc. University Hospital Geneva, Geneva, Switzerland
    • Grignaschi, Nathalie. University Hospital Basle, Basle, Switzerland
    • Magnin, Jean-Luc. Kantonsspital Freiburg, Freiburg, Switzerland
    • Thormann, Wolfgang. University of Berne, Berne, Switzerland
    • Todesco, Liliane. University Hospital Basle, Basle, Switzerland
    • Werner, Dominique. University Hospital Lausanne, Lausanne, Switzerland
    Dokumententyp
    • Postprint
    Sprache
    • Mehrere sprachen
    Veröffentlicht in
    • LaboratoriumsMedizin, 2008, vol. 32, no. 5, p. 372-381. Walter de Gruyter
    Andere elektronische Ausgabe
    OAI-PMH-ID
    • oai:doc.rero.ch:303966
    Summary
    In addition to the monographs which have been published recently by the working group "Drug Monitoring” of the Swiss Society of Clinical Chemistry (SSCC) [1, 2], new monographs have been written. The aim of these monographs is to provide an overview on the information which is important for the request and interpretation of the results. Therefore, the targeted readers are laboratory health professionals and the receivers of the reports. In this series, aminoglycoside as well as glycopeptide antibiotics are presented. In addition, two antimycotic drugs, which are regularly quantified in sera of intensive care patients, are described. Also, the monograph on mebendazole is shown. This drug is often used in high doses for the treatment of infections with Echinococcus multilocularis for which the measurement of drug concentrations in serum is recommended. Information on the indication for therapeutic drug monitoring (TDM), protein binding, metabolic pathways and enzymes involved, elimination half-life and elimination routes, and therapeutic or toxic concentrations is provided. Because pre-analytical considerations are of particular importance for therapeutic drug monitoring, there is also information given at which time the determination of the drug concentration is reasonable and when steady-state concentrations are reached after changing the dose. Furthermore, the stability of the drug and its metabolite(s) after blood sampling is described. For readers with a specific interest, references to important publications are provided. The number of the monographs will be continuously increased. The updated files are presented on the homepage of the SSCC (www.sscc.ch). We hope that these monographs are helpful for the better handling of therapeutic drug monitoring and we are looking forward to comments by the readers